|
Smoking Cessation And Nicotine De-Addiction Market size is set to grow by USD 36.98 billion from 2024-2028, rising adoption of online retailing boost the market, Technavio
Friday, June 21, 2024
NEW YORK, June 18, 2024 /PRNewswire/ -- The global smoking cessation and nicotine de-addiction market size is estimated to grow by USD 36.98 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.84% during the forecast period. Rising adoption of online retailing is driving market growth, with a trend towards new marketing initiatives. However, health issues associated with smoking cessation products poses a challenge. Key market players include Alchem International Pvt. Ltd., Alkalon AS, Alvogen Iceland ehf, Axcentria Pharmaceuticals, British American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. Z o.o. Sp. K, Cipla Inc., Dr Reddys Laboratories Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Services Inc., Lil Drug Store Products Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris International Inc., Qnovia, Tvape, and Walgreens Boots Alliance Inc..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
Smoking Cessation And Nicotine De-Addiction Market Scope
Report Coverage
Details
Base year 2023
Historic period
2018 - 2022
Forecast period
2024-2028
Growth momentum & CAGR Accelerate at a CAGR of 15.84%
Market growth 2024-2028
USD 36983.3 million
Market structure
Fragmented
YoY growth 2022-2023 (%) 13.32
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution North America at 30%
Key countries
US, Germany, China, Canada, and India
Key companies profiled Alchem International Pvt. Ltd., Alkalon AS, Alvogen Iceland ehf, Axcentria Pharmaceuticals, British American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. Z o.o. Sp. K, Cipla Inc., Dr Reddys
Laboratories Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Services Inc., Lil Drug Store Products Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris
International Inc., Qnovia, Tvape, and Walgreens Boots Alliance Inc.
Market Driver
Vendors in the smoking cessation and nicotine de-addiction market are implementing innovative advertising strategies to attract consumers. Notable examples include JUUL's first television campaign, which showcased adult testimonials from ex-smokers aged 37 to 54 years. The campaign, titled "Taste Test Drive," featured Dale Earnhardt Jr. Discussing his personal smoking struggles and quitting journey. Such initiatives are expected to expand the global market for smoking cessation and nicotine de-addiction during the forecast period.
The Nicotine De-Addiction and Smoking Cessation market is experiencing significant growth due to increasing awareness and efforts to reduce the use of tobacco products. Neurotransmitters like Nicotine are the primary drivers of this market. Companies are focusing on developing innovative chronic disease management solutions, such as Chantix and Nicotine Replacement Therapies (NRTs). These solutions aim to help individuals quit smoking by addressing the underlying addiction to Nicotine. Additionally, the use of technology, such as mobile apps and wearable devices, is on the rise in this market. These tools provide personalized support and real-time tracking to help individuals manage their addiction and quit smoking. The market is also witnessing an increase in the use of Cytisinicline, a smoking cessation drug, and various other smoking cessation methods like Hypnosis and Acupuncture. The market is expected to continue growing as more individuals seek to improve their health and quit smoking.
Research report provides comprehensive data on impact of trend. For more details- Download a Sample Report
Market Challenges
-- The smoking cessation and nicotine de-addiction market may experience
hindrances due to increasing awareness regarding the potential health
risks associated with nicotine gums, patches, lozenges, and
e-cigarettes. Long-term use of nicotine gums can lead to health issues
such as hair loss, skin irritation, elevated blood pressure, irregular
heartbeat, insulin resistance, gastrointestinal problems, and nausea.
Nicotine patches can cause skin irritation, itching, dizziness, and
headache. E-cigarettes contain toxic ingredients like propylene glycol
and vegetable glycerin, and produce harmful chemicals such as
acetaldehyde, acrolein, and formaldehyde, which can lead to lung and
cardiovascular diseases. These health concerns may deter consumers from
adopting these products, thereby impacting market growth.
-- The Smoking Cessation and Nicotine De-Addiction market faces several
challenges. Chronic use of cigarettes leads to nicotine dependence, a
significant issue in this market. Drugs like Chronic, Cytisinicline, and
Varenicline are used for nicotine replacement therapy. However, their
effectiveness varies from person to person. Irritability and difficulty
concentrating are common side effects, making it crucial to manage
patient expectations. Additionally, the cost of these treatments can be
a barrier for many individuals seeking help. The market also requires
innovative solutions to address the psychological aspects of nicotine
addiction. The use of behavioral therapies, mobile apps, and
telemedicine services can help increase accessibility and affordability.
Overall, the Smoking Cessation and Nicotinic De-Addiction market
requires a multi-faceted approach to address the challenges of nicotine
addiction effectively.
For more insights on driver and challenges - Request a sample report!
Segment Overview
This smoking cessation and nicotine de-addiction market report extensively covers market segmentation by
1. Distribution Channel
-- 1.1 Drug stores and retailers
-- 1.2 Hospital pharmacies
-- 1.3 Online retail
2. Product
-- 2.1 E-cigarette
-- 2.2 NRT
-- 2.3 Drug therapy
3. Geography
-- 3.1 North America
-- 3.2 Europe
-- 3.3 Asia
-- 3.4 Rest of World (ROW)
1.1 Drug stores and retailers- The drug stores and retailers segment remains a significant player in the global smoking cessation and nicotine de-addiction market in 2023. Technological advancements and enhanced customer service at leading pharmacies foster customer loyalty. These businesses keep consumers informed about treatments and ensure seamless access to quality pharmaceuticals. However, sales in this sector have been decreasing due to the rise of online shopping. To boost offline sales, vendors are expanding into local and regional markets, selling through specialty stores and other retail formats. This trend intensifies market competition, leading to moderate growth in segment revenue during the forecast period.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) - Download a Sample Report
Research Analysis
The Smoking Cessation and Nicotine De-Addiction Market encompasses a range of products and therapies designed to help individuals quit tobacco use. These include nicotine replacement therapies (NRTs) such as lozenges, gums, sprays, transdermal patches, sublingual tablets, and inhalers. Drug therapy options, like Zyban and Chantix, which are not nicotine-based but work by affecting neurotransmitters, are also part of this market. Non-nicotinic pharmacological therapies, such as bupropion and varenicline, are another category. Behavioral therapies, including counseling, are additionally utilized in smoking cessation efforts. A recent Phase III study, ORCA-3, focused on the use of cytisine, an alkaloid found in the laburnum plant, as a potential smoking cessation aid. Drug Class Insights and Achieve Life Sciences are among the entities providing insights and innovations in this domain, working towards the development of effective and safer solutions for chronic disease prevention through nicotine de-addiction.
Market Research Overview
The Smoking Cessation and Nicotine De-Addiction market encompasses a range of solutions designed to help individuals quit smoking and reduce their dependence on nicotine. These offerings include therapeutic approaches such as behavioral therapy, nicotine replacement therapy (NRT), and pharmacological interventions. Additionally, innovative technologies like mobile apps, wearable devices, and telehealth services are gaining popularity in this market. The market is driven by the growing awareness of the health risks associated with smoking and the desire to improve overall well-being. Furthermore, the increasing prevalence of nicotine addiction and the availability of various treatment options are fueling market growth. The market is expected to continue expanding as more effective and accessible solutions emerge.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
-- Distribution Channel
-- Drug Stores And Retailers
-- Hospital Pharmacies
-- Online Retail
-- Product
-- E-cigarette
-- NRT
-- Drug Therapy
-- Geography
-- North America
-- Europe
-- Asia
-- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/smoking-cessation-and-nicotine-de-addiction-market-size-is-set-to-grow-by-usd-36-98-billion-from-2024-2028--rising-adoption-of-online-retailing-boost-the-market-technavio-302174031.html
SOURCE Technavio
|
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
|
